表紙
市場調查報告書

第二意見的全球市場:各疾病 (癌症,心臟障礙,糖尿病,外傷等)、各服務供應商 (醫院,線上/離線服務供應商,醫療保險企業)、各地區的未來預測 (2015∼2020年)

Medical Second Opinion Market - Forecast (2020 - 2025)

出版商 IndustryARC 商品編碼 351136
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
第二意見的全球市場:各疾病 (癌症,心臟障礙,糖尿病,外傷等)、各服務供應商 (醫院,線上/離線服務供應商,醫療保險企業)、各地區的未來預測 (2015∼2020年) Medical Second Opinion Market - Forecast (2020 - 2025)
出版日期: 2020年03月11日內容資訊: 英文 120 Pages
簡介

全球第二意見市場,今後預計以18.2%的年複合成長率 (CAGR) 成長,2020年達到34億美元的規模。在各地區中,北美各國佔全球整體的43%。由於受到了歐巴馬健保案法案的醫療保險的重新評估,及行動醫療的發達容易取得醫療資料,成為在該地區的市場成長的大的要素。

本報告提供全球醫療第二意見的相關市場相關分析,整體市場結構、特性,及主要推動及阻礙市場要素,各疾病、各業者、各地區的趨勢預測 (今後6年份),今後的市場擴大的動向,主要企業簡介等相關調查與考察。

第1章 全球第二意見市場概要

第2章 摘要整理

第3章 全球第二意見市場:市場環境

  • 市場佔有率分析
  • 比較分析
    • 產品的基準
    • 終端用戶的特性
    • 專利分析
    • 前五名公司的財務分析

第4章 全球第二意見市場:影響要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場課題
  • 產業吸引力
    • 供應商方面談判力
    • 客戶方面談判力
    • 新加入企業的威脅
    • 替代產品的威脅
    • 產業內競爭的強度

第5章 全球第二意見市場:策略性分析

  • 價值鏈分析
  • 價格趨勢分析
  • 市場機會分析
  • 產品生命週期分析
  • 供應商和經銷商

第6章 全球第二意見市場:各疾病

  • 簡介
  • 癌症
  • 糖尿病
  • 心臟障礙
  • 神經病變
  • 眼障礙
  • 肺障礙
  • 腎臟障礙
  • 過敏
  • 外傷
  • 其他

第7章 全球第二意見市場:服務供應商

  • 簡介
  • 醫院
  • 第二意見提供企業
  • 醫療保險公司
  • 線上服務
  • 其他

第8章 全球第二意見市場:各地區

  • 簡介
  • 南北美洲
    • 美國
    • 加拿大
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 其他
  • 其他的國家 (RoW)
    • 中東
    • 非洲

第9章 市場熵

  • 新產品的銷售
  • 企業合併、收購 (M&A)、產業合作、產業聯盟、合資企業 (JV)

第10章 投資機會

第11章 主要企業簡介 (總合40家公司以上)

  • Advance Medical
  • Mediguide America
  • Johns Hopkins USA
  • Best Doctors
  • Cleveland Clinic
  • Bupa Global
  • WorldCare International Inc.
  • Grand Rounds
  • XMRI.com
  • HCA Hospitals
  • Penn Medicine
  • Cynergy Care
  • MediAngels.com
  • Medical Second Opinion Pvt. Ltd.
  • UC San Diego Health System
  • AXA PPP Healthcare

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HCR 0024

The Global Medical second opinion market recorded revenue of $2249million in 2017 and is estimated to grow at a CAGR of 18.2% throughout the forecast period 2018-2023. US region has seen a significant growth in the medical second option market with its ability to embrace the changing technology and use it for the betterment of lives. The US market collected revenue of $939million in 2017 and is estimated to grow at a CAGR of 17.1% throughout the forecast period. UK has dominated the global market in the European segment by recording revenue of $284.7million in 2017 and is projected to grow at a CAGR of 18.1% through the forecast period. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.

What is Medical Second Opinion?

Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward flow in medical second opinion services mainly due to health, financial and legal costs involved in the treatment.

The medical second opinion market is classified on the basis of disorders. The demand for a medical second opinion is high in chronic ailments such as Ocular disorders, Neurological disorders, pulmonary disorders and Nephrological disorders.

Medical Second Opinion Market

Market Research and Market Trends of Medical Second Opinion Market

Lately, many people all over the world take second opinion for Chronic Obstructive Pulmonary disease (COPD). COPD is an obstructive and chronic inflammatory lung disease which causes obstruction for airflow from the lungs. The main cause of COPD is due to tobacco smoking. COPD is often occurred in people exposed to fumes from burning fuel and heating in poorly ventilated homes. The pulmonary disorders market has recorded revenue of $81.50million in 2017 and is estimated to grow at a CAGR of 18.9% till 2023.

The exposure of Asbestos fibers might cause lung cancer due to the silicate fibers that can persist for lifetime in lung tissue. The workplace is a common source of exposure to asbestos fibers, since these fibers are used in both thermal and acoustic insulation materials. Due to this, the use of asbestos has been banned in many of the countries including the USA. The Cancer segment in the global medical second opinion market recorded revenue of $554.46million in 2017 and is estimated to grow at a CAGR of 18.7% throughout the forecast period 2018-2023.

Diabetes disorder has a major effect on medical second opinion market since patients diagnosed with diabetes tend to consider second opinion when they are uncertain with the diagnosis or unsure about treatment plan or the treatment plan suggested by the physicians has not resulted in any major changes. The diabetes segment recorded revenue of $324.92million in the year 2017 and is projected to grow rapidly at a CAGR of 16.8% till 2023.

Who are the Major Players in Medical Second Opinion market?

The companies referred to in the market research report includes Johns Hopkins USA, WorldCare International Inc., Cynergy Care, Mediguide America, Medical Second Opinion Pvt. Ltd., UC San Diego Health System and more than 25 companies.

What is our report scope?

The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2023.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1. Executive Summary

2. Medical Second Opinion - Market Landscape

  • 2.1. Market Share Analysis
  • 2.2. Comparative Analysis
    • 2.2.1. Product Benchmarking
    • 2.2.2. End User Profiling
    • 2.2.3. Top 5 Financials Analysis

3. Medical Second Opinion - Market Forces

  • 3.1. Market Drivers
  • 3.2. Market Constraints
  • 3.3. Market Challenges
  • 3.4. Attractiveness of the Animal Feed Testing Industry
    • 3.4.1. Power of Suppliers
    • 3.4.2. Power of Customers
    • 3.4.3. Threats from New entrants
    • 3.4.4. Threat of Substitution
    • 3.4.5. Degree of Competition

4. Medical Second Opinion Market - Strategic Analysis

  • 4.1. Value Chain Analysis
  • 4.2. Pricing Analysis
  • 4.3. Opportunities Analysis
  • 4.4. Product/Market Life Cycle Analysis
  • 4.5. Suppliers and Distributors

6. Medical Second Opinion Market - By Disorders

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Diabetes
  • 6.4. Cardiac disorders
  • 6.5. Neurological disorders
  • 6.6. Ocular disorders
  • 6.7. Pulmonary disorders
  • 6.8. Nephrological disorders
  • 6.9. Allergies
  • 6.10. Injuries
  • 6.11. Digestive diseases and Cancers
  • 6.12. Eye diseases
  • 6.13. Geriatric conditions
  • 6.14. Hematologic blood disorders
  • 6.15. Kidney and Urological diseases
  • 6.16. Lung diseases and cancers
  • 6.17. Pediatric cancers and diseases
  • 6.18. Rheumatologic disorders
  • 6.19. Obstetrics and Gynecological disorders and cancers
  • 6.20. Skin disorders
  • 6.21. Others

7. Medical Second Opinion Market - By Service Providers

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Medical Second Opinion Providing Companies
  • 7.4. Health Insurance Companies
  • 7.5. Online Services
  • 7.6. Others

8. Medical Second Opinion Market -by Geography

  • 8.1. North America
    • 8.1.1. U.S.
    • 8.1.2. Canada
    • 8.1.3. Mexico
  • 8.2. South America
    • 8.2.1. Brazil
    • 8.2.2. Venezuela
    • 8.2.3. Argentina
    • 8.2.4. Ecuador
    • 8.2.5. Peru
    • 8.2.6. Colombia
    • 8.2.7. Costa Rica
  • 8.3. Europe
    • 8.3.1. U.K
    • 8.3.2. Germany
    • 8.3.3. Italy
    • 8.3.4. France
    • 8.3.5. Netherlands
    • 8.3.6. Belgium
    • 8.3.7. Spain
    • 8.3.8. Denmark
  • 8.4. APAC
    • 8.4.1. China
    • 8.4.2. Australia
    • 8.4.3. South Korea
    • 8.4.4. India
    • 8.4.5. Taiwan
    • 8.4.6. Malaysia
    • 8.4.7. Hong Kong
  • 8.5. Middle East& Africa
  • 8.6. Russia
  • 8.7. Israel
  • 8.8. Other

9. Market Entropy

  • 9.1 New Product Launches
  • 9.2 M&As, Collaborations, JVs, Partnership

10. Company Profiles

  • 10.1. Johns Hopkins USA
  • 10.2. WorldCare International Inc.
  • 10.3. Cynergy Care
  • 10.4. Mediguide America
  • 10.5. Medical Second Opinion Pvt. Ltd.
  • 10.6. UC San Diego Health System
  • 10.7. Company 7
  • 10.8. Company 8
  • 10.9. Company 9
  • 10.10. Company 10
  • 10.11. Company 11
  • 10.12. Company 12
  • 10.13. Company 13
  • 10.14. Company 14

More than 20 Companies are profiled in this Research Report*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer